World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02240342
Date of registration: 11/09/2014
Prospective Registration: No
Primary sponsor: Hospital Universitario La Fe
Public title: Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve
Scientific title: Ovarian Rejuvenation: Regeneration of Ovarian Follicles in Women With Poor Ovarian Reserve by Autologous Transplantation of Bone Marrow Derived Progenitors Cells in Peripheral Blood. Pilot Study.
Date of first enrolment: September 2014
Target sample size: 20
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02240342
Study type:  Interventional
Study design:  Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Spain
Contacts
Name:     Antonio Pellicer, Professor
Address: 
Telephone: +34961244000
Email: pellicer_ant@gva.es
Affiliation: 
Name:     Susana Martínez, Doctor
Address: 
Telephone: +34961244000
Email: susamc12@hotmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- < or= 40 years old

- FSH<15UI/L

- poor ovarian response after controlled ovarian stimulation with conventional doses
(<3 oocytes) or two episodes of poor ovarian response after ovarian stimulation with
maximal doses even if young or normal ovarian reserve study.

- Antral follicle count>2

- >1 antral follicle in the perfused ovary

- AMH between 0,5 and 3pmol/L

- regular menstrual bleeding each 21-35 days

- To be candidate to autologous hematopoietic progenitors transplantation

Exclusion Criteria:

-



Age minimum: 18 Years
Age maximum: 40 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Ovarian Reserve
Intervention(s)
Drug: Bone marrow transplant into ovarian artery
Primary Outcome(s)
Ovarian reserve [Time Frame: 6 months]
Secondary Outcome(s)
Ovarian response to controlled ovarian stimulation [Time Frame: 6 months]
Secondary ID(s)
NEOFOL2014
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history